Reshape Biotech raised $20 million Series A led by Astanor Ventures joined by YC, R7, ACME, 21stBio and angel investors.
01 April 2024
01 April 2024
Total investments received (USD): 29.23M
Round value (USD): 20M
Company: Reshape Biotech
Related deals
Bactolife raised €30m Series B led by Cross Border Impact Ventures and EIFO, joined by Novo Holdings, family office Athos and the Gates Foundation
Investments
27 December 2025
Netherlands
Austria
Switzerland
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain
United Kingdom